Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world, Point-of-care, Randomized, Parallel Group, Open, 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus

NCT03090464 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03090464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03090464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world, Point-of-care, Randomized, Parallel Group, Open, 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 8, 2017
Completion date
May 21, 2018
Enrollment
328 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus